SAN DIEGO, March 14, 2017 /PRNewswire/ -- Inova Diagnostics, a worldwide leader in autoimmune diagnostic reagents and systems for the clinical laboratory, is pleased to announce the launch of QUANTA Flash(®) Calprotectin, an assay which aids in the diagnosis of Inflammatory Bowel Disease (IBD), and can help differentiate IBD from Irritable Bowel Syndrome (IBS). The assay is now available in territories where diagnostic products with CE mark may be marketed. QUANTA Flash Calprotectin is one of 32 CE marked assays available on BIO-FLASH(®), a random access chemiluminescent instrument, and can be run simultaneously with other QUANTA Flash assays.
Photo - http://mma.prnewswire.com/media/237960/inova_diagnostics___autoimmune_chemiluminescent_analyzer.jpg [http://mma.prnewswire.com/media/237960/inova_diagnostics___autoimmune_chemiluminescent_analyzer.jpg]
The accurate detection of calprotectin levels can provide critical information to physicians determining the appropriate care of millions of patients suffering from gastrointestinal disorders. QUANTA Flash Calprotectin is a chemiluminescent immunoassay for the quantitative determination of fecal calprotectin in extracted human stool samples.
QUANTA Flash Calprotectin delivers precise quantification, with an analytical measuring range of up to 3,500 mg/kg, and can provide insight where follow up testing is performed. According to Michael Mahler, PhD, Vice President of Research and Development for Inova Diagnostics, "We are very pleased to launch this high performing assay to meet the increasing demand from laboratories worldwide. Gastrointestinal pain is a common reason for seeking medical attention. Inaccurate results at the screening level can contribute to unnecessary procedures and increased healthcare costs. QUANTA Flash Calprotectin, with its broad dynamic range and high accuracy, can improve care while helping reduce costs."
About Inova Diagnostics, Inc.Inova Diagnostics is a privately held company headquartered in San Diego, California, and is a part of Werfen, a global leader in in vitro diagnostics (IVD) with a long term commitment to providing high quality, innovative solutions for hospitals and clinical laboratories to enhance patient care. Inova Diagnostics manufactures IVD systems and reagents for autoimmune disease that are used around the world, and is a leader in the development and commercialization of novel autoimmune technologies and diagnostic markers.
About QUANTA Flash Calprotectin QUANTA Flash Calprotectin is a chemiluminescent immunoassay for the quantitative determination of fecal calprotectin in extracted human stool samples. Elevated levels of fecal calprotectin, in conjunction with clinical findings and other laboratory tests, can aid in the diagnosis of inflammatory bowel disease (ulcerative colitis and Crohn's disease), and in the differentiation of IBD from irritable bowel syndrome.
About BIO-FLASHBIO-FLASH is a random access chemiluminescent instrument for the autoimmune laboratory which delivers results in as little as 30 minutes. BIO-FLASH offers a wide analytical measuring range and precise quantification for greater confidence in results. BIO-FLASH is a progressive step forward to handle routine, specialized and STAT immunology tests in-house with greater speed and precision than ever before.
CONTACT: Inova Diagnostics, Inc., A Werfen Company, Tel. +1 858 586 9900